FDA fast tracks drugs for Ebola and Marburg viruses

September 19, 2012

FDA has granted fast-track designation for the development of AVI-7288 and AVI-7537 (Sarepta Therapeutics), for the treatment of Marburg virus and Ebola virus, respectively.